In the treatment of DIC, it is recommended to administer AT-III preparations asanticoagulant therapy when antithrombin activity is decreased.18 In many cases of DIC associated with infectious disease, AT-IIIactivity decreases, so administration of AT preparations is often necessary. The gene discussed is SERPINC1; the disease is infectious disease.